Skip to main content

Table 4 Fully adjusted risks (hazard ratios) of death within 28 days and cardiorenal complications within 1 year after admission,  in COVID-19 vs. influenza

From: Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data

 

Type 1 diabetes (677 hospitalized patients)

 

Death

HF

CKD

CRD

MI

Stroke

Number of events

73

22

28

47

8

9

COVID-19 vs. influenza

2.44 (1.60–3.72)

0.79 (0.31–1.99)

0.66 (0.28–1.55)

0.70 (0.37–1.31)

0.58 (0.13–2.56)

0.85 (0.22–3.28)

 

Type 2 diabetes (15,439 hospitalized patients)

 

Death

HF

CKD

CRD

MI

Stroke

Number of events

2199

560

407

920

140

186

COVID-19 vs. influenza

2.81 (2.59–3.06)

0.67 (0.56–0.80)

0.98 (0.80–1.20)

0.78 (0.68–0.89)

0.65 (0.46–0.92)

0.85 (0.63–1.15)

  1. Diabetes patients with type 1 (T1D) or type 2 diabetes (T2D) hospitalized for Covid-19 or influenza. Risks were estimated with age, sex, HF, CKD, ischemic heart disease, stroke, peripheral artery disease, previous pneumonia, COPD, obesity and rheumatologic disease as covariates and presented as adjusted hazard ratio values including 95% confidence interval